BayesHammer: Bayesian clustering for error correction in single-cell sequencing
|
journal
|
January 2013 |
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA
|
journal
|
March 2015 |
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline
|
journal
|
March 2012 |
Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease
|
journal
|
November 2006 |
Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients
|
journal
|
April 2018 |
State of the art in cystic fibrosis pharmacology—Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti‐methicillin‐resistant Staphylococcus aureus (MRSA) antibiotics
|
journal
|
September 2019 |
PATRIC as a unique resource for studying antimicrobial resistance
|
journal
|
July 2017 |
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
|
journal
|
March 1992 |
Biopython: freely available Python tools for computational molecular biology and bioinformatics
|
journal
|
March 2009 |
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
|
journal
|
October 2018 |
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
|
journal
|
September 2010 |
Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998
|
journal
|
January 2015 |
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function
|
journal
|
October 2013 |
Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis
- Autry, Elizabeth B.; Rybak, Jeffrey M.; Leung, Noelle R.
-
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Vol. 36, Issue 1
https://doi.org/10.1002/phar.1681
|
journal
|
January 2016 |
Cystic Fibrosis Foundation Pulmonary Guideline*. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection
|
journal
|
December 2014 |
Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates: PBP2 localization in S. aureus
|
journal
|
November 2004 |
The Length of the Staphylococcus aureus Protein A Polymorphic Region Regulates Inflammation: Impact on Acute and Chronic Infection
|
journal
|
April 2012 |
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations
|
journal
|
July 2013 |
Improvement of Phylogenies after Removing Divergent and Ambiguously Aligned Blocks from Protein Sequence Alignments
|
journal
|
August 2007 |
Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA
|
journal
|
October 2015 |
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe
|
journal
|
August 2016 |
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America
|
journal
|
December 2018 |
Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus
|
journal
|
April 2000 |
Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis
|
journal
|
January 2011 |
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry
|
journal
|
July 2016 |
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
|
journal
|
January 2014 |
Targeting of PBP1 by β-lactams Determines recA/SOS Response Activation in Heterogeneous MRSA Clinical Strains
|
journal
|
April 2013 |
Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents
|
journal
|
May 2011 |
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model
|
journal
|
July 2017 |
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
|
journal
|
May 2012 |
Quantitation of mecA Transcription in Oxacillin-Resistant Staphylococcus aureus Clinical Isolates
|
journal
|
June 2003 |
Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance
|
journal
|
May 2015 |
Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
|
journal
|
March 2010 |
Cystic Fibrosis
|
journal
|
August 2016 |
RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes
|
journal
|
February 2015 |
Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
|
journal
|
August 2019 |
MUSCLE: a multiple sequence alignment method with reduced time and space complexity
|
journal
|
August 2004 |
Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae
|
journal
|
April 2007 |
Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?
|
journal
|
May 2015 |
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure
|
journal
|
January 2016 |
Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis
|
journal
|
May 2018 |
Ceftaroline Is Active against Heteroresistant Methicillin-Resistant Staphylococcus aureus Clinical Strains despite Associated Mutational Mechanisms and Intermediate Levels of Resistance
|
journal
|
July 2014 |
Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals
|
journal
|
October 2016 |
MUSCLE: multiple sequence alignment with high accuracy and high throughput
|
journal
|
March 2004 |
Evidence for a dual role of PBP1 in the cell division and cell separation of Staphylococcus aureus
|
journal
|
May 2009 |
Cystic Fibrosis
|
journal
|
May 2014 |
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
|
journal
|
February 2016 |
PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
|
journal
|
August 2014 |
Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species
|
journal
|
January 2013 |
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates
|
journal
|
September 2018 |
High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations
|
journal
|
December 2016 |
β-Lactams Interfering with PBP1 Induce Panton-Valentine Leukocidin Expression by Triggering sarA and rot Global Regulators of Staphylococcus aureus
|
journal
|
April 2011 |
mecA-blaZ Corepressors in Clinical Staphylococcus aureus Isolates
|
journal
|
April 2003 |